Porfiromycin

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NamePorfiromycin
Drug Alias Name泊非霉素porfiromycinumporfiromycine甲基丝裂霉素porfiromicina +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsHead and Neck NeoplasmsCarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgYale University
Active IndicationsN/A
Inactive IndicationsHead and Neck NeoplasmsCarcinoma

Other Information

ATC CodeN/A
Related LinksKEGG